Amgen’s stock hit by expectations its obesity pipeline is facing a longer wait By: MarketWatch October 31, 2023 at 11:59 AM EDT Amgen Inc.'s stock fell 3.3% Tuesday despite an earnings beat and raised guidance. Obesity drugs were to blame. Read More >> Related Stocks: AbbVie Amgen Eli Lilly Novo Nordisk A/S ADR
